Clinical trial

B-Cell Hematologic Malignancy Vaccination Registry

NCT02298816

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2014-08-01

PhaseN/A

Study timeline

Study start (actual)2014-08-01Date precision: month

Registry last updated2024-10-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Monoclonal Gammopathy of Undetermined Significanceunresolved

Multiple Myelomaunresolved

Waldenstrom Macroglobulinemiaunresolved

Lymphocytosisunresolved

Lymphoma, Non-Hodgkinunresolved

B-Cell Chronic Lymphocytic Leukemiaunresolved

Hematological Malignanciesunresolved

Interventions

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

Vince Lombardi Cancer Cliniccollaborator

Mapped research locations

MilwaukeeWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02298816 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.